Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents

Claim 2

A compound of the formula: ##STR40## wherein: R is hydrogen, loweralkyl, aralkyl, aryl; or mono- or disubstituted aryl wherein the substituents are chloro; R 1 is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched, cyclic and unsaturated alkyl groups; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, loweralkanoylamino, aroylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, loweralkanoylamino, aroylamino, loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or trisubstituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, loweralkanoylamino, aroylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substututed by amino, loweralkanoylamino, aroylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N--R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 2 is hydrogen; loweralkyl; hydroxyloweralkyl; loweralkanoylamino; aminoloweralkyl, dimethylaminoloweralkyl; haloloweralkyl; guanidinoloweralkyl; mercaptoloweralkyl; loweralkylthioloweralkyl; aralkyl, heteroaralkyl, substituted aralkyl, or substituted heteroaralkyl, where the alkyl portion is loweralkyl and the substituents are halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; mercaptoloweralkyl; or loweralkylthioloweralkyl; in the group: ##STR41## A and B are joined, together with the nitrogen and carbon atoms to which they are attached to form a pyrrole ring having the formula: ##STR42## wherein R 5 is hydrogen, lower alkyl, aralkyl, or aryl, R 6 is hydrogen; loweralkyl; cycloalkyl; aryl; aralkyl; heteroaryl; loweralkyloxy; loweralkylthio; aryloxy; arylthio; arloweralkyloxy; arloweralkylthio; hydroxy; loweralkanoyloxy; loweralkanoyl; halo; amino; loweralkylamino; arloweralkylamino; heteroloweralkylamino; acylamino in which the acyl group may be loweralkanoyl, aroyl, heteroaroyl or heteroloweralkanoyl; carbamoyl or N-substituted carbamoyloxy; including any of these groups containing an aromatic ring wherein said ring may be mono-, di- or trisubstituted by loweralkyl, loweralkoxy, loweralkylthio, halo, hydroxy, aryl, aryloxy, arylthio or aralkyl; R 3 is ##STR43## where n is 1-3; and the R a 's and R b 's on each carbon are independently hydrogen; or loweralkyl; and R 4 is hydroxy; loweralkoxy; aralkoxy; or aryloxy, or mono- or disubstituted aryloxy wherein the substituents are chloro; and a pharmaceutically acceptable salt thereof wherein in said R-R 6 groups the aralkyl and heteroaralkyl substituents represent aryl or heteroaryl groups attached through a straight or branched chain hydrocarbon of from one to six carbon atoms, selected from the group consisting of benzyl, phenethyl, 3,3-diphenylpropyl, 3-indolylmethyl; aryl represents phenyl, naphthyl, or biphenyl; and, heteroaryl represents any 5- or 6-membered aromatic ring containing from one to three nitrogen, oxygen and sulfur heteroatoms and is selected from the group consisting of pyridyl, thienyl, furyl, imidazolyl, and thiazolyl, as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring, and which is selected from the group consisting of indolyl, quinolinyl, isoquinolinyl, benzimidazolyl, benzothiazolyl, benzthienyl, and napthyridyl.

Claim 3

A pharmaceutical composition useful in the treatment of hypertension which comprises a pharmaceutically acceptable carrier; an antihypertensively effective amount of a compound of claim 1; and, an antihypertensively effective amount of an antihypertensive and/or diuretic compound selected from the group consisting of acetazolamide, amiloride, aminophylline, atenolol, bendroflumethiazide, benzthiazide, bumetanide, chlorothalidone, chlorothiazide, clonidine, cryptenamine acetates and cryptenamine tannates, cyclothiazide, deserpidine, diazoxide, diltiazem, (S)-1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-[[4-(2-thienyl)-1H-imidazol-2-yl]phenoxy]-2-propanol, ethacrynic acid, flumethiazide, furosemide, guanethidene sulfate, hydralazine hydrochloride, hydrochlorothiazaide, hydroflumethiazide, (+)-4-[3-[-[2-(1-hydroxycyclohexyl)ethyl]4-oxo-2-thiazolidinyl]propyl]-benzoic acid, indacrinone and variable ratios of its enantiomers, merethoxylline procaine, methylclothiazide, methyldopa, methyldopate hydrochloride, metolazone, metoprolol tartate, minoxidil, naldolol, nifedipine, pargyline hydrochloride, pindolol, polythiazide, prazosin, propranolol, quinethazone, rauwolfia serpentia, rescinnamine, reserpine, sodium ethacrynate, sodium nitroprusside, spironolactone, ticrynafen, timolol, triamterene, trichlormethiazide, trimethophan camsylate, and verapamil.

Claim 4

A pharmaceutical composition useful in the treatment of hypertension which comprises a pharmaceutically acceptable carrier; an antihypertensively effective amount of a compound of claim 1; and an antihypertensively effective amount of hydrochlorothiazide.

Claim 5

A pharmaceutical composition useful in the treatment of hypertension which comprises a pharmaceutically acceptable carrier; an antihypertensively effective amount of a compound of claim 1, and an antihypertensively effective amount of timolol.

Claim 6

A pharmaceutical composition useful in the treatment of hypertension which comprises a pharmaceutically acceptable carrier; an antihypertensively effective amount of a compound of claim 1; and an antihypertensively effective amount of manipulated indacrinone enantiomer ratio.

Claim 7

A pharmaceutical composition useful in treating hypertension comprising a pharmaceutically acceptable carrier and an antihypertensively effective amount of a compound of the formula: ##STR44## wherein: R is hydrogen; loweralkyl; aralkyl, aryl; or mono- or disubstituted aryl wherein the substituents are chloro; R 1 is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched, cyclic and unsaturated alkyl groups; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, loweralkanoylamino, aroylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, loweralkanoylamino, aroylamino loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, loweralkanoylamino, aroylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, loweralkanoylamino, aroylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N--R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 2 is hydrogen; loweralkyl; hydroxyloweralkyl; loweralkanoylamino; aminoloweralkyl; dimethylaminoloweralkyl; haloloweralkyl; guanidinoloweralkyl; mercaptoloweralkyl; loweralkylthioloweralkyl; aralkyl, heteroalkyl, substituted aralkyl, or substituted heteroaralkyl, where the alkyl portion is loweralkyl and the substituents are halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; mercaptoloweralkyl; or loweralkylthioloweralkyl; in the group; ##STR45## A and B are joined, together with the nitrogen and carbon atoms to which they are attached to form a pyrrole ring having the formula: ##STR46## wherein R 5 is hydrogen, lower alkyl, aralkyl, or aryl; R 6 is hydrogen; loweralkyl; cycloalkyl; aryl; aralkyl; heteroaryl; loweralkyloxy; loweralkylthio; aryloxy; arylthio; arloweralkyloxy; arloweralkylthio; hydroxy; loeralkanoyloxy; loweralkanoyl; halo; amino; loweralkylamino; arloweralkylamino; heteroloweralkylamino; acylamino in which the acyl group may be loweralkanoyl, aroyl, heteroaroyl or heteroloweralkanoyl; carbamoyl or N-substituted carbamoyloxy; including any of these groups containing an aromatic ring wherein said ring may be mono-, di- or trisubstituted by loweralkyl, loweralkoxy, loweralkylthio, halo, hydroxy, aryl, aryloxy, arylthio or aralkyl; R 3 is ##STR47## where n is 1-3; and the R a 's and R b 's on each carbon are independently hydrogen; or loweralkyl; and R 4 is hydroxy; loweralkoxy, aralkoxy; or aryloxy, or mono- or disubstituted aryloxy wherein the substituents are chloro; and a pharmaceutically acceptable salt thereof wherein in said R-R 6 groups the aralkyl and heteroalkyl substituents represent aryl or heteroaryl groups attached through a straight or branched chain hydrocarbon of from one to six carbon atoms selected from the group consisting of benzyl, phenethyl, 3,3-diphenylpropyl, 3-indolylmethyl; aryl represents phenyl, naphthyl, or biphenyl; and, heteroaryl represents any 5-or 6-membered aromatic ring containing from one to three nitrogen, oxygen and sulfur heteroatoms and is selected from the group consisting of pyridyl, thienyl, furyl, imidazolyl, and thiazolyl, as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring, and which is selected from the group consisting of indolyl, quinolinyl, isoquinolinyl, benzimidazolyl, benzothiazolyl, benzthienyl, and naphthyridyl.

Claim 8

A pharmaceutical composition useful in treating hypertension comprising a pharmaceutically acceptable carrier and an antihypertensively effective amount of a compound of the formula: ##STR44## wherein: R is hydrogen; loweralkyl; aralkyl, aryl; or mono- or disubstituted aryl wherein the substituents are chloro; R 1 is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched, cyclic and unsaturated alkyl groups; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, carboxamido, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, loweralkanoylamino, aroylamino; substituted loweralkylamino wherein the substituent can be halo, hydroxy, alkoxy or cyano; arloweralkylamino; cyclic amino; oxo, thio or ureido; aryloxy; arylthio; aralkyloxy; aralkylthio; benzofused cycloalkyl or bicycloalkyl of from 8-12 carbon atoms; aryl or heteroaryl which may be mono-, di- or trisubstituted by loweralkyl, hydroxy, loweralkoxy, halo, amino, loweralkanoylamino, aroylamino loweralkylthio or aminoloweralkyl; benzofused cycloalkyl or bicycloalkyl of from 8 to 12 carbon atoms; arloweralkyl; arloweralkenyl; heteroloweralkyl and heteroloweralkenyl in which the aryl or heteroaryl rings may be mono-, di- or tri-substituted by halo, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, aminoloweralkyl, loweralkanoylamino, aroylamino, carboxy, haloloweralkyl, nitro, cyano or sulfonamido; aralkyl or heteroaralkyl which include branched loweralkyl groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, loweralkanoylamino, aroylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; any of the arloweralkyl or alkenyl and heteroloweralkyl or alkenyl groups described above in which the aryl or heteroaryl ring is partially or completely hydrogenated; substituted loweralkyl having the formula R A 1 (CH 2 ) n --Q--(CH 2 ) m wherein n is 0-2, m is 1-3, R A 1 is aryl or heteroaryl optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, SO, SO 2 , N--R B 1 , CONR C 1 , NR C 1 CO, CH═CH wherein R B 1 is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R C 1 is hydrogen, or loweralkyl; R 2 is hydrogen; loweralkyl; hydroxyloweralkyl; loweralkanoylamino; aminoloweralkyl; dimethylaminoloweralkyl; haloloweralkyl; guanidinoloweralkyl; mercaptoloweralkyl; loweralkylthioloweralkyl; aralkyl, heteroalkyl, substituted aralkyl, or substituted heteroaralkyl, where the alkyl portion is loweralkyl and the substituents are halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; mercaptoloweralkyl; or loweralkylthioloweralkyl; in the group; ##STR45## A and B are joined, together with the nitrogen and carbon atoms to which they are attached to form a pyrrole ring having the formula: ##STR46## wherein R 5 is hydrogen, lower alkyl, aralkyl, or aryl; R 6 is hydrogen; loweralkyl; cycloalkyl; aryl; aralkyl; heteroaryl; loweralkyloxy; loweralkylthio; aryloxy; arylthio; arloweralkyloxy; arloweralkylthio; hydroxy; loeralkanoyloxy; loweralkanoyl; halo; amino; loweralkylamino; arloweralkylamino; heteroloweralkylamino; acylamino in which the acyl group may be loweralkanoyl, aroyl, heteroaroyl or heteroloweralkanoyl; carbamoyl or N-substituted carbamoyloxy; including any of these groups containing an aromatic ring wherein said ring may be mono-, di- or trisubstituted by loweralkyl, loweralkoxy, loweralkylthio, halo, hydroxy, aryl, aryloxy, arylthio or aralkyl; R 3 is ##STR47## where n is 1-3; and the R a 's and R b 's on each carbon are independently hydrogen; or loweralkyl; and R 4 is hydroxy; loweralkoxy, aralkoxy; or aryloxy, or mono- or disubstituted aryloxy wherein the substituents are chloro; and a pharmaceutically acceptable salt thereof wherein in said R-R 6 groups the aralkyl and heteroalkyl substituents represent aryl or heteroaryl groups attached through a straight or branched chain hydrocarbon of from one to six carbon atoms selected from the group consisting of benzyl, phenethyl, 3,3-diphenylpropyl, 3-indolylmethyl; aryl represents phenyl, naphthyl, or biphenyl; and, heteroaryl represents any 5-or 6-membered aromatic ring containing from one to three nitrogen, oxygen and sulfur heteroatoms and is selected from the group consisting of pyridyl, thienyl, furyl, imidazolyl, and thiazolyl, as well as any bicyclic group in which any of the above heterocyclic rings is fused to another aromatic ring, and which is selected from the group consisting of indolyl, quinolinyl, isoquinolinyl, benzimidazolyl, benzothiazolyl, benzthienyl, and naphthyridyl.